B
Brian P. James
Researcher at Discovery Institute
Publications - 28
Citations - 1685
Brian P. James is an academic researcher from Discovery Institute. The author has contributed to research in topics: Pancreatic cancer & Cancer cell. The author has an hindex of 12, co-authored 27 publications receiving 1285 citations. Previous affiliations of Brian P. James include University of Texas MD Anderson Cancer Center.
Papers
More filters
Journal ArticleDOI
Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer.
Scott Kopetz,Jayesh Desai,Emily Chan,J. R. Hecht,Peter J. O'Dwyer,Dipen M. Maru,Van K. Morris,Filip Janku,Arvind Dasari,Woonbook Chung,Jean Pierre J. Issa,Peter Gibbs,Peter Gibbs,Brian P. James,Garth Powis,K. B. Nolop,Suman Bhattacharya,Leonard B. Saltz +17 more
TL;DR: Single-agent vemurafenib did not show meaningful clinical activity in patients with BRAF V600E mutant CRC, and combination strategies are now under development and may be informed by the presence of intratumor heterogeneity of KRAS and NRAS mutations.
Journal ArticleDOI
EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2
Jia Shen,Weiya Xia,Yekaterina B. Khotskaya,Longfei Huo,Kotaro Nakanishi,Seung Oe Lim,Yi Du,Yan Wang,Wei Chao Chang,Wei Chao Chang,Chung-Hsuan Chen,Jennifer L. Hsu,Jennifer L. Hsu,Jennifer L. Hsu,Yun Wu,Yung Carmen Lam,Brian P. James,Xiuping Liu,Chang Gong Liu,Dinshaw J. Patel,Mien Chie Hung +20 more
TL;DR: The study reveals a previously unrecognized function of EGFR in miRNA maturation and demonstrates how EGFR is likely to function as a regulator of AGO2 through novel post-translational modification, suggesting that modulation of miRNA biogenesis is important for stress response in tumour cells and has potential clinical implications.
Journal ArticleDOI
Hypoxia triggers Hedgehog-mediated tumor stromal interactions in pancreatic cancer
Taly R. Spivak-Kroizman,Galen Hostetter,Richard G. Posner,Meraj Aziz,Chengcheng Hu,Michael J. Demeure,Daniel D. Von Hoff,Sunil R. Hingorani,Timothy B. Palculict,Julie G. Izzo,Galina Kiriakova,Mena Abdelmelek,Geoffrey Bartholomeusz,Brian P. James,Garth Powis +14 more
TL;DR: It is suggested that increased HIF-1α produced by hypoxic tumors triggers the desmoplasic reaction in pancreatic cancer, which is then amplified by a feed forward loop involving cycles of decreased blood flow and increased hypoxia.
Journal ArticleDOI
ETS2 Mediated Tumor Suppressive Function and MET Oncogene Inhibition in Human Non–Small Cell Lung Cancer
Mohamed Kabbout,Melinda M. Garcia,Junya Fujimoto,Diane D. Liu,Denise Woods,Chi Wan Chow,Gabriela Mendoza,Amin Momin,Brian P. James,Luisa M. Solis,Carmen Behrens,J. Jack Lee,Ignacio I. Wistuba,Humam Kadara +13 more
TL;DR: The findings point to a tumor suppressor role for ETS2 in human NSCLC pathogenesis through inhibition of the MET proto-oncogene.
Journal ArticleDOI
Glutamine depletion regulates Slug to promote EMT and metastasis in pancreatic cancer
Maria Victoria Recouvreux,Matthew R. Moldenhauer,Koen M.O. Galenkamp,Michael Jung,Brian P. James,Yijuan Zhang,Andrew M. Lowy,Anindya Bagchi,Cosimo Commisso +8 more
TL;DR: It is demonstrated that nutrient stress caused by glutamine deprivation drives epithelial-mesenchymal transition (EMT) and aggressive behaviors in PDAC cells through up-regulation of the EMT master regulator Slug.